Torrent Pharmaceuticals Ltd. expects to garner significant revenue synergies from its acquisition of Unichem Laboratories Ltd.'s domestic branded business for Rs 3,600 crore.
In an interview with BloombergQuint, Samir Mehta, chairman at Torrent Pharma also outlined the company's product portfolio, international business outlook and future growth plans.
You can watch the full interview here:
Also Read: Unichem's Shareholders Will Be Rewarded Adequately, Says Chairman And MD
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
